The Associated Press - 30 January 1996
A modified version of a protein extracted from whey blocked the AIDS virus from infecting cells in the test tube, researchers report.
If further tests go well, the modified protein might be put in a cream or foam that could be used along with condoms, said researcher A. Robert Neurath.
Neurath is head of the Laboratory of Biochemical Virology at the Lindsley F. Kimball Research Institute of the New York Blood Center. He and colleagues reported the test-tube result in the February issue of Nature Medicine.
An AIDS expert sid the work left some key questions unanswered.
Whey is produced when milk is made into cheese. Most of it is then used in other products, including ice cream, bread, pie crust and canned soups.
For the new work, scientists modified a whey protein called beta-lactoglobulin to produce a substance they named B69. They found that B69 latched onto a protein structure called CD4 on the surface of cells. That kept the AIDS virus from using CD4 as an entryway into the cells.
In the test tube, B69 blocked infection by free-floating HIV and by HIV traveling in infected cells, Neurath said. Someday, B69 might be put into an over-the-counter product, perhaps in combination with a virus-killing compound, he said.
The work was supported by the National Institutes of Health and by Philip Morris Cos.
Dr. Jeffrey Laurence, an AIDS researcher at Cornell Medical College in New York, cautioned that research shows HIV can infect some cells -- including cells in the vagina and rectum -- without using CD4.
Neurath said preliminary work suggests B69 might block other cell sites that have been proposed as alternative entryways for HIV.
Laurence also said B69 will have to be tested to see if it will harm the tissues it is applied to. Neurath said tests in rabbits and rats suggest side effects are unlikely to be a problem.
960130
AP960107
Copyright © 1996 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .